Global Allogeneic Stem Cell Transplantation Supply, Demand and Key Producers, 2023-2029

August 2023 | 124 pages | ID: G37AA1135D89EN
GlobalInfoResearch

Abstracts

The global Allogeneic Stem Cell Transplantation market size is expected to reach $ 1521 million by 2029, rising at a market growth of 5.7% CAGR during the forecast period (2023-2029).

This report studies the global Allogeneic Stem Cell Transplantation demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Allogeneic Stem Cell Transplantation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Allogeneic Stem Cell Transplantation that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Allogeneic Stem Cell Transplantation total market, 2018-2029, (USD Million)

Global Allogeneic Stem Cell Transplantation total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Allogeneic Stem Cell Transplantation total market, key domestic companies and share, (USD Million)

Global Allogeneic Stem Cell Transplantation revenue by player and market share 2018-2023, (USD Million)

Global Allogeneic Stem Cell Transplantation total market by Type, CAGR, 2018-2029, (USD Million)

Global Allogeneic Stem Cell Transplantation total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Allogeneic Stem Cell Transplantation market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mesoblast Limited, Gamida Cell Ltd., Novartis International AG, Cellectis SA, Magenta Therapeutics Inc., Fate Therapeutics Inc., Cynata Therapeutics Limited, Kiadis Pharma N.V and Takeda Pharmaceutical Company Limited, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Allogeneic Stem Cell Transplantation market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Allogeneic Stem Cell Transplantation Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Allogeneic Stem Cell Transplantation Market, Segmentation by Type

• Unmodified Stem Cell Transplant
• T-cell Depleted Transplant
• Cord Blood Transplant
• Donor Lymphocyte Infusion

Global Allogeneic Stem Cell Transplantation Market, Segmentation by Application

• Hospital
• Ambulatory Surgical Center
• Others

Companies Profiled:

• Mesoblast Limited
• Gamida Cell Ltd.
• Novartis International AG
• Cellectis SA
• Magenta Therapeutics Inc.
• Fate Therapeutics Inc.
• Cynata Therapeutics Limited
• Kiadis Pharma N.V
• Takeda Pharmaceutical Company Limited
• JCR Pharmaceuticals Co., Ltd.
• Pluristem Therapeutics Inc.
• Celularity Inc.
• Lineage Cell Therapeutics Inc.
• Nohla Therapeutics Inc.
• Orchard Therapeutics Plc

Key Questions Answered

1. How big is the global Allogeneic Stem Cell Transplantation market?

2. What is the demand of the global Allogeneic Stem Cell Transplantation market?

3. What is the year over year growth of the global Allogeneic Stem Cell Transplantation market?

4. What is the total value of the global Allogeneic Stem Cell Transplantation market?

5. Who are the major players in the global Allogeneic Stem Cell Transplantation market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Allogeneic Stem Cell Transplantation Introduction
1.2 World Allogeneic Stem Cell Transplantation Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Allogeneic Stem Cell Transplantation Total Market by Region (by Headquarter Location)
  1.3.1 World Allogeneic Stem Cell Transplantation Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Allogeneic Stem Cell Transplantation Market Size (2018-2029)
  1.3.3 China Allogeneic Stem Cell Transplantation Market Size (2018-2029)
  1.3.4 Europe Allogeneic Stem Cell Transplantation Market Size (2018-2029)
  1.3.5 Japan Allogeneic Stem Cell Transplantation Market Size (2018-2029)
  1.3.6 South Korea Allogeneic Stem Cell Transplantation Market Size (2018-2029)
  1.3.7 ASEAN Allogeneic Stem Cell Transplantation Market Size (2018-2029)
  1.3.8 India Allogeneic Stem Cell Transplantation Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Allogeneic Stem Cell Transplantation Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Allogeneic Stem Cell Transplantation Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Allogeneic Stem Cell Transplantation Consumption Value (2018-2029)
2.2 World Allogeneic Stem Cell Transplantation Consumption Value by Region
  2.2.1 World Allogeneic Stem Cell Transplantation Consumption Value by Region (2018-2023)
  2.2.2 World Allogeneic Stem Cell Transplantation Consumption Value Forecast by Region (2024-2029)
2.3 United States Allogeneic Stem Cell Transplantation Consumption Value (2018-2029)
2.4 China Allogeneic Stem Cell Transplantation Consumption Value (2018-2029)
2.5 Europe Allogeneic Stem Cell Transplantation Consumption Value (2018-2029)
2.6 Japan Allogeneic Stem Cell Transplantation Consumption Value (2018-2029)
2.7 South Korea Allogeneic Stem Cell Transplantation Consumption Value (2018-2029)
2.8 ASEAN Allogeneic Stem Cell Transplantation Consumption Value (2018-2029)
2.9 India Allogeneic Stem Cell Transplantation Consumption Value (2018-2029)

3 WORLD ALLOGENEIC STEM CELL TRANSPLANTATION COMPANIES COMPETITIVE ANALYSIS

3.1 World Allogeneic Stem Cell Transplantation Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Allogeneic Stem Cell Transplantation Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Allogeneic Stem Cell Transplantation in 2022
  3.2.3 Global Concentration Ratios (CR8) for Allogeneic Stem Cell Transplantation in 2022
3.3 Allogeneic Stem Cell Transplantation Company Evaluation Quadrant
3.4 Allogeneic Stem Cell Transplantation Market: Overall Company Footprint Analysis
  3.4.1 Allogeneic Stem Cell Transplantation Market: Region Footprint
  3.4.2 Allogeneic Stem Cell Transplantation Market: Company Product Type Footprint
  3.4.3 Allogeneic Stem Cell Transplantation Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Allogeneic Stem Cell Transplantation Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Allogeneic Stem Cell Transplantation Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Allogeneic Stem Cell Transplantation Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Allogeneic Stem Cell Transplantation Consumption Value Comparison
  4.2.1 United States VS China: Allogeneic Stem Cell Transplantation Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Allogeneic Stem Cell Transplantation Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Allogeneic Stem Cell Transplantation Companies and Market Share, 2018-2023
  4.3.1 United States Based Allogeneic Stem Cell Transplantation Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Allogeneic Stem Cell Transplantation Revenue, (2018-2023)
4.4 China Based Companies Allogeneic Stem Cell Transplantation Revenue and Market Share, 2018-2023
  4.4.1 China Based Allogeneic Stem Cell Transplantation Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Allogeneic Stem Cell Transplantation Revenue, (2018-2023)
4.5 Rest of World Based Allogeneic Stem Cell Transplantation Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Allogeneic Stem Cell Transplantation Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Allogeneic Stem Cell Transplantation Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Allogeneic Stem Cell Transplantation Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Unmodified Stem Cell Transplant
  5.2.2 T-cell Depleted Transplant
  5.2.3 Cord Blood Transplant
  5.2.4 Donor Lymphocyte Infusion
5.3 Market Segment by Type
  5.3.1 World Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023)
  5.3.2 World Allogeneic Stem Cell Transplantation Market Size by Type (2024-2029)
  5.3.3 World Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Allogeneic Stem Cell Transplantation Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Ambulatory Surgical Center
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023)
  6.3.2 World Allogeneic Stem Cell Transplantation Market Size by Application (2024-2029)
  6.3.3 World Allogeneic Stem Cell Transplantation Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Mesoblast Limited
  7.1.1 Mesoblast Limited Details
  7.1.2 Mesoblast Limited Major Business
  7.1.3 Mesoblast Limited Allogeneic Stem Cell Transplantation Product and Services
  7.1.4 Mesoblast Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Mesoblast Limited Recent Developments/Updates
  7.1.6 Mesoblast Limited Competitive Strengths & Weaknesses
7.2 Gamida Cell Ltd.
  7.2.1 Gamida Cell Ltd. Details
  7.2.2 Gamida Cell Ltd. Major Business
  7.2.3 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product and Services
  7.2.4 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Gamida Cell Ltd. Recent Developments/Updates
  7.2.6 Gamida Cell Ltd. Competitive Strengths & Weaknesses
7.3 Novartis International AG
  7.3.1 Novartis International AG Details
  7.3.2 Novartis International AG Major Business
  7.3.3 Novartis International AG Allogeneic Stem Cell Transplantation Product and Services
  7.3.4 Novartis International AG Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Novartis International AG Recent Developments/Updates
  7.3.6 Novartis International AG Competitive Strengths & Weaknesses
7.4 Cellectis SA
  7.4.1 Cellectis SA Details
  7.4.2 Cellectis SA Major Business
  7.4.3 Cellectis SA Allogeneic Stem Cell Transplantation Product and Services
  7.4.4 Cellectis SA Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Cellectis SA Recent Developments/Updates
  7.4.6 Cellectis SA Competitive Strengths & Weaknesses
7.5 Magenta Therapeutics Inc.
  7.5.1 Magenta Therapeutics Inc. Details
  7.5.2 Magenta Therapeutics Inc. Major Business
  7.5.3 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Services
  7.5.4 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Magenta Therapeutics Inc. Recent Developments/Updates
  7.5.6 Magenta Therapeutics Inc. Competitive Strengths & Weaknesses
7.6 Fate Therapeutics Inc.
  7.6.1 Fate Therapeutics Inc. Details
  7.6.2 Fate Therapeutics Inc. Major Business
  7.6.3 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Services
  7.6.4 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Fate Therapeutics Inc. Recent Developments/Updates
  7.6.6 Fate Therapeutics Inc. Competitive Strengths & Weaknesses
7.7 Cynata Therapeutics Limited
  7.7.1 Cynata Therapeutics Limited Details
  7.7.2 Cynata Therapeutics Limited Major Business
  7.7.3 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product and Services
  7.7.4 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Cynata Therapeutics Limited Recent Developments/Updates
  7.7.6 Cynata Therapeutics Limited Competitive Strengths & Weaknesses
7.8 Kiadis Pharma N.V
  7.8.1 Kiadis Pharma N.V Details
  7.8.2 Kiadis Pharma N.V Major Business
  7.8.3 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product and Services
  7.8.4 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Kiadis Pharma N.V Recent Developments/Updates
  7.8.6 Kiadis Pharma N.V Competitive Strengths & Weaknesses
7.9 Takeda Pharmaceutical Company Limited
  7.9.1 Takeda Pharmaceutical Company Limited Details
  7.9.2 Takeda Pharmaceutical Company Limited Major Business
  7.9.3 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product and Services
  7.9.4 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
  7.9.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.10 JCR Pharmaceuticals Co., Ltd.
  7.10.1 JCR Pharmaceuticals Co., Ltd. Details
  7.10.2 JCR Pharmaceuticals Co., Ltd. Major Business
  7.10.3 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product and Services
  7.10.4 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 JCR Pharmaceuticals Co., Ltd. Recent Developments/Updates
  7.10.6 JCR Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
7.11 Pluristem Therapeutics Inc.
  7.11.1 Pluristem Therapeutics Inc. Details
  7.11.2 Pluristem Therapeutics Inc. Major Business
  7.11.3 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Services
  7.11.4 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Pluristem Therapeutics Inc. Recent Developments/Updates
  7.11.6 Pluristem Therapeutics Inc. Competitive Strengths & Weaknesses
7.12 Celularity Inc.
  7.12.1 Celularity Inc. Details
  7.12.2 Celularity Inc. Major Business
  7.12.3 Celularity Inc. Allogeneic Stem Cell Transplantation Product and Services
  7.12.4 Celularity Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Celularity Inc. Recent Developments/Updates
  7.12.6 Celularity Inc. Competitive Strengths & Weaknesses
7.13 Lineage Cell Therapeutics Inc.
  7.13.1 Lineage Cell Therapeutics Inc. Details
  7.13.2 Lineage Cell Therapeutics Inc. Major Business
  7.13.3 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Services
  7.13.4 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Lineage Cell Therapeutics Inc. Recent Developments/Updates
  7.13.6 Lineage Cell Therapeutics Inc. Competitive Strengths & Weaknesses
7.14 Nohla Therapeutics Inc.
  7.14.1 Nohla Therapeutics Inc. Details
  7.14.2 Nohla Therapeutics Inc. Major Business
  7.14.3 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Services
  7.14.4 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Nohla Therapeutics Inc. Recent Developments/Updates
  7.14.6 Nohla Therapeutics Inc. Competitive Strengths & Weaknesses
7.15 Orchard Therapeutics Plc
  7.15.1 Orchard Therapeutics Plc Details
  7.15.2 Orchard Therapeutics Plc Major Business
  7.15.3 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product and Services
  7.15.4 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
  7.15.5 Orchard Therapeutics Plc Recent Developments/Updates
  7.15.6 Orchard Therapeutics Plc Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Allogeneic Stem Cell Transplantation Industry Chain
8.2 Allogeneic Stem Cell Transplantation Upstream Analysis
8.3 Allogeneic Stem Cell Transplantation Midstream Analysis
8.4 Allogeneic Stem Cell Transplantation Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Allogeneic Stem Cell Transplantation Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Allogeneic Stem Cell Transplantation Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Allogeneic Stem Cell Transplantation Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Allogeneic Stem Cell Transplantation Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Allogeneic Stem Cell Transplantation Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Allogeneic Stem Cell Transplantation Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Allogeneic Stem Cell Transplantation Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Allogeneic Stem Cell Transplantation Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Allogeneic Stem Cell Transplantation Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Allogeneic Stem Cell Transplantation Players in 2022
Table 12. World Allogeneic Stem Cell Transplantation Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Allogeneic Stem Cell Transplantation Company Evaluation Quadrant
Table 14. Head Office of Key Allogeneic Stem Cell Transplantation Player
Table 15. Allogeneic Stem Cell Transplantation Market: Company Product Type Footprint
Table 16. Allogeneic Stem Cell Transplantation Market: Company Product Application Footprint
Table 17. Allogeneic Stem Cell Transplantation Mergers & Acquisitions Activity
Table 18. United States VS China Allogeneic Stem Cell Transplantation Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Allogeneic Stem Cell Transplantation Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Allogeneic Stem Cell Transplantation Companies, Headquarters (States, Country)
Table 21. United States Based Companies Allogeneic Stem Cell Transplantation Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Allogeneic Stem Cell Transplantation Revenue Market Share (2018-2023)
Table 23. China Based Allogeneic Stem Cell Transplantation Companies, Headquarters (Province, Country)
Table 24. China Based Companies Allogeneic Stem Cell Transplantation Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Allogeneic Stem Cell Transplantation Revenue Market Share (2018-2023)
Table 26. Rest of World Based Allogeneic Stem Cell Transplantation Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Allogeneic Stem Cell Transplantation Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Allogeneic Stem Cell Transplantation Revenue Market Share (2018-2023)
Table 29. World Allogeneic Stem Cell Transplantation Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023) & (USD Million)
Table 31. World Allogeneic Stem Cell Transplantation Market Size by Type (2024-2029) & (USD Million)
Table 32. World Allogeneic Stem Cell Transplantation Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023) & (USD Million)
Table 34. World Allogeneic Stem Cell Transplantation Market Size by Application (2024-2029) & (USD Million)
Table 35. Mesoblast Limited Basic Information, Area Served and Competitors
Table 36. Mesoblast Limited Major Business
Table 37. Mesoblast Limited Allogeneic Stem Cell Transplantation Product and Services
Table 38. Mesoblast Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Mesoblast Limited Recent Developments/Updates
Table 40. Mesoblast Limited Competitive Strengths & Weaknesses
Table 41. Gamida Cell Ltd. Basic Information, Area Served and Competitors
Table 42. Gamida Cell Ltd. Major Business
Table 43. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product and Services
Table 44. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Gamida Cell Ltd. Recent Developments/Updates
Table 46. Gamida Cell Ltd. Competitive Strengths & Weaknesses
Table 47. Novartis International AG Basic Information, Area Served and Competitors
Table 48. Novartis International AG Major Business
Table 49. Novartis International AG Allogeneic Stem Cell Transplantation Product and Services
Table 50. Novartis International AG Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Novartis International AG Recent Developments/Updates
Table 52. Novartis International AG Competitive Strengths & Weaknesses
Table 53. Cellectis SA Basic Information, Area Served and Competitors
Table 54. Cellectis SA Major Business
Table 55. Cellectis SA Allogeneic Stem Cell Transplantation Product and Services
Table 56. Cellectis SA Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Cellectis SA Recent Developments/Updates
Table 58. Cellectis SA Competitive Strengths & Weaknesses
Table 59. Magenta Therapeutics Inc. Basic Information, Area Served and Competitors
Table 60. Magenta Therapeutics Inc. Major Business
Table 61. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Services
Table 62. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Magenta Therapeutics Inc. Recent Developments/Updates
Table 64. Magenta Therapeutics Inc. Competitive Strengths & Weaknesses
Table 65. Fate Therapeutics Inc. Basic Information, Area Served and Competitors
Table 66. Fate Therapeutics Inc. Major Business
Table 67. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Services
Table 68. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Fate Therapeutics Inc. Recent Developments/Updates
Table 70. Fate Therapeutics Inc. Competitive Strengths & Weaknesses
Table 71. Cynata Therapeutics Limited Basic Information, Area Served and Competitors
Table 72. Cynata Therapeutics Limited Major Business
Table 73. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product and Services
Table 74. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Cynata Therapeutics Limited Recent Developments/Updates
Table 76. Cynata Therapeutics Limited Competitive Strengths & Weaknesses
Table 77. Kiadis Pharma N.V Basic Information, Area Served and Competitors
Table 78. Kiadis Pharma N.V Major Business
Table 79. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product and Services
Table 80. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Kiadis Pharma N.V Recent Developments/Updates
Table 82. Kiadis Pharma N.V Competitive Strengths & Weaknesses
Table 83. Takeda Pharmaceutical Company Limited Basic Information, Area Served and Competitors
Table 84. Takeda Pharmaceutical Company Limited Major Business
Table 85. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product and Services
Table 86. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 88. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 89. JCR Pharmaceuticals Co., Ltd. Basic Information, Area Served and Competitors
Table 90. JCR Pharmaceuticals Co., Ltd. Major Business
Table 91. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product and Services
Table 92. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. JCR Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 94. JCR Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 95. Pluristem Therapeutics Inc. Basic Information, Area Served and Competitors
Table 96. Pluristem Therapeutics Inc. Major Business
Table 97. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Services
Table 98. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Pluristem Therapeutics Inc. Recent Developments/Updates
Table 100. Pluristem Therapeutics Inc. Competitive Strengths & Weaknesses
Table 101. Celularity Inc. Basic Information, Area Served and Competitors
Table 102. Celularity Inc. Major Business
Table 103. Celularity Inc. Allogeneic Stem Cell Transplantation Product and Services
Table 104. Celularity Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Celularity Inc. Recent Developments/Updates
Table 106. Celularity Inc. Competitive Strengths & Weaknesses
Table 107. Lineage Cell Therapeutics Inc. Basic Information, Area Served and Competitors
Table 108. Lineage Cell Therapeutics Inc. Major Business
Table 109. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Services
Table 110. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Lineage Cell Therapeutics Inc. Recent Developments/Updates
Table 112. Lineage Cell Therapeutics Inc. Competitive Strengths & Weaknesses
Table 113. Nohla Therapeutics Inc. Basic Information, Area Served and Competitors
Table 114. Nohla Therapeutics Inc. Major Business
Table 115. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Services
Table 116. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Nohla Therapeutics Inc. Recent Developments/Updates
Table 118. Orchard Therapeutics Plc Basic Information, Area Served and Competitors
Table 119. Orchard Therapeutics Plc Major Business
Table 120. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product and Services
Table 121. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Allogeneic Stem Cell Transplantation Upstream (Raw Materials)
Table 123. Allogeneic Stem Cell Transplantation Typical Customers
List of Figure
Figure 1. Allogeneic Stem Cell Transplantation Picture
Figure 2. World Allogeneic Stem Cell Transplantation Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Allogeneic Stem Cell Transplantation Total Market Size (2018-2029) & (USD Million)
Figure 4. World Allogeneic Stem Cell Transplantation Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Allogeneic Stem Cell Transplantation Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Allogeneic Stem Cell Transplantation Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Allogeneic Stem Cell Transplantation Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Allogeneic Stem Cell Transplantation Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Allogeneic Stem Cell Transplantation Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Allogeneic Stem Cell Transplantation Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Allogeneic Stem Cell Transplantation Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Allogeneic Stem Cell Transplantation Revenue (2018-2029) & (USD Million)
Figure 13. Allogeneic Stem Cell Transplantation Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Allogeneic Stem Cell Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 16. World Allogeneic Stem Cell Transplantation Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Allogeneic Stem Cell Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 18. China Allogeneic Stem Cell Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Allogeneic Stem Cell Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Allogeneic Stem Cell Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Allogeneic Stem Cell Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Allogeneic Stem Cell Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 23. India Allogeneic Stem Cell Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Allogeneic Stem Cell Transplantation by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Allogeneic Stem Cell Transplantation Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Allogeneic Stem Cell Transplantation Markets in 2022
Figure 27. United States VS China: Allogeneic Stem Cell Transplantation Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Allogeneic Stem Cell Transplantation Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Allogeneic Stem Cell Transplantation Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Allogeneic Stem Cell Transplantation Market Size Market Share by Type in 2022
Figure 31. Unmodified Stem Cell Transplant
Figure 32. T-cell Depleted Transplant
Figure 33. Cord Blood Transplant
Figure 34. Donor Lymphocyte Infusion
Figure 35. World Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2018-2029)
Figure 36. World Allogeneic Stem Cell Transplantation Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Allogeneic Stem Cell Transplantation Market Size Market Share by Application in 2022
Figure 38. Hospital
Figure 39. Ambulatory Surgical Center
Figure 40. Others
Figure 41. Allogeneic Stem Cell Transplantation Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source